Home/Tubulis Technologies/Dr. Ingo Lehrke
DI

Dr. Ingo Lehrke

Chief Business Officer

Tubulis Technologies

Therapeutic Areas

Tubulis Technologies Pipeline

DrugIndicationPhase
TUB-040Solid tumors (e.g., ovarian, NSCLC) targeting NaPi2bPhase 1
TUB-030Solid tumors targeting 5T4Phase 1